WSJ -- Biogen Idec Inc. increased the wholesale price of popular multiple-sclerosis drug Avonex by 6% last month, while Ireland’s Elan Corp. gave a 7% boost to the price of MS therapy Tysabri, which it sells with Biogen.
WSJ -- Biogen Idec Inc. increased the wholesale price of popular multiple-sclerosis drug Avonex by 6% last month, while Ireland’s Elan Corp. gave a 7% boost to the price of MS therapy Tysabri, which it sells with Biogen.
